← Leaderboards
Hong Xin
Lsu Health Sciences Center
$1,783,401
Attributed
$1,783,401
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2013–25$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,783,401 · 5
By mechanism
R41$824,645 · 2
R21$794,904 · 2
R03$163,852 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antifungal Therapy”
- Arturo Casadevall · Johns Hopkins University$17,905,550
- Tamara L Doering · Washington University$12,975,537
- Christina A Cuomo · Broad Institute, Inc.$12,084,249
- Scott G Filler · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$11,775,663
- Robert Andrew Cramer · Sloan-Kettering Inst Can Research$11,340,729
- David R Boulware · University Of Minnesota$10,610,536
Research focus
Antifungal TherapyEpitopesSynthetic PeptidePeptidesAntibodiesCell SurfacePeptide VaccinesImmunityInfectionVaccinesAffectDisseminated CandidiasisMorbidity - Disease RateHospitalsSepsisLifeAntifungal AgentsGlycopeptidesFructosediphosphate AldolaseMedicalPassive ImmunizationCandidaCandida AlbicansImmunocompromised Host
Grant awards (9)
Liposome-displayed peptide vaccine against disseminated candidiasis by clinically-relevant Candida species$300,000
R41 · FY2025 · AI · contact PI
Liposome-displayed peptide vaccine against disseminated candidiasis by clinically-relevant Candida species$300,000
R41 · FY2024 · AI · contact PI
Development of immunotherapeutic strategies and vaccines against multidrug resistant C. auris disseminated infection$183,750
R21 · FY2023 · AI · contact PI
Development of immunotherapeutic strategies and vaccines against multidrug resistant C. auris disseminated infection$220,500
R21 · FY2022 · AI · contact PI
Double Chimeric Peptide Vaccine Feasible for Human Use that Protects against Disseminated Candidiasis caused by medically important Candida species$224,645
R41 · FY2018 · AI · contact PI
Design of a mimotope-peptide based double epitope vaccine against candidiasis$171,191
R21 · FY2016 · AI · contact PI
Design of a mimotope-peptide based double epitope vaccine against candidiasis$219,463
R21 · FY2015 · AI · contact PI
Synthetic glycopeptide vaccines that enhance resistance to candidiasis$81,926
R03 · FY2014 · AI · contact PI
Synthetic glycopeptide vaccines that enhance resistance to candidiasis$81,926
R03 · FY2013 · AI · contact PI